This site is intended for Healthcare Professionals only.

Tag: Avacta Group

spot_imgspot_img

Avacta halts sale of Covid-19 rapid antigen lateral flow test to boost Omicron sensitivity

Britain’s biotech firm Avacta Group on Monday (January 10) announced halting sales of its Covid-19 rapid antigen lateral flow test AffiDX to replace antibodies...